Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: There is a new letter out.

I particularly like this part of the letter (in bold)

"Beginning in 2007, a series of reexaminations was initiated against four key patents in the MMP™ Portfolio (the ‘148, ‘336, ‘584 and ‘749). As we have stated previously, this is a time-consuming, detailed process that can take several years. No one can forecast the progress, or the eventual outcome, of the re-examination processes, but we remain optimistic for a variety of reasons, including those outlined in Dr. Choate’s paper with a link, included in my June 16, 2008 letter to the shareholders, which can be found on Patriot’s website."

Variety of reasons?

  1. German Validation
  2. 52 or so licensees
  3. Donald Shrock
  4. Exparte re-exam
Share
New Message
Please login to post a reply